Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Surgery
Published in: Journal of Gastrointestinal Surgery 8/2016

01-08-2016 | Original Article

C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery

Authors: A. Giardino, G. Spolverato, P. Regi, I. Frigerio, F. Scopelliti, R. Girelli, Z. Pawlik, P. Pederzoli, C. Bassi, G. Butturini

Published in: Journal of Gastrointestinal Surgery | Issue 8/2016

Login to get access

Abstract

Background

The association between postoperative inflammatory markers and risk of complications after pancreaticoduodenectomy (PD) is controversial. We sought to assess the diagnostic value of perioperative C-reactive protein (CRP) and procalcitonin (PCT) levels in the early identification of patients at risk for complications after PD.

Methods

In 2014, 84 patients undergoing elective PD were enrolled in a prospective database. Clinicopathological characteristics, CRP and PCT, as well as short-term outcomes, such as complications and pancreatic fistula, were analyzed. Complications and pancreatic fistula were defined based on the Clavien-Dindo classification and the International Study Group on Pancreatic Fistula (ISGPF) classification, respectively. High CRP and PCT were classified using cut-off values based on ROC curve analysis.

Results

The majority (73.8 %) of patients had pancreatic adenocarcinoma. CRP and PCT levels over the first 5 postoperative days (POD) were higher among patients who experienced a complication versus those who did not (p < 0.001). Postoperative CRP and PCT levels were also higher among patients who developed a grade B or C pancreatic fistula (p < 0.05). A CRP concentration >84 mg/l on POD 1 (AUC 0.77) and >127 mg/l on POD 3 (AUC 0.79) was associated with the highest risk of overall complications (OR 6.86 and 9.0, respectively; both p < 0.001). Similarly patients with PCT >0.7 mg/dl on POD 1 (AUC 0.67) were at higher risk of developing a postoperative complication (OR 3.33; p = 0.024). On POD 1, a CRP >92 mg/l (AUC 0.72) and a PCT >0.4 mg/dl (AUC 0.70) were associated with the highest risk of pancreatic fistula (OR 5.63 and 5.62, respectively; both p < 0.05).

Conclusions

CRP and PCT concentration were associated with an increased risk of developing complications and clinical relevant pancreatic fistula after PD. Use of these biomarkers may help identify those patients at highest risk for perioperative morbidity and help guide postoperative management of patients undergoing PD.
Appendix
Available only for authorised users
Literature
1.
Fu S, Shen S, Li S, Hu W, Hua Y, Kuang M, et al. Risk factors and outcomes of postoperative pancreatic fistula after pancreatico-duodenectomy: an audit of 532 consecutive cases. BMC Surgery, 2015. 15–34.
2.
Paniccia A, Hosokawa P, Henderson W, Schulick RD, Edil BH, Mccarter MD, et al. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma. JAMA Surg, 2015. 80045: p1–10.
3.
Joliat G, Petermann D, Demartines N, Schäfer M. Prediction of Complications After Pancreaticoduodenectomy Validation of a Postoperative Complication Score. Pancreas, 2015. 44(8): p1323–8.CrossRef
4.
Nagai S, Fujii T, Kodera Y, Kanda M, Sahin TT, Kanzaki a, et al. Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula. Ann Surg Oncol, 2011. 2329: p18–37.
5.
Petermann D, Demartines N, Schafer M. Severe postoperative complications adversely affect long-term survival after R1 resection for pancreatic head adenocarcinoma. World J Surg, 2013. 37: p1901–8.CrossRef
6.
Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al. Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery, 2005. 138: p8–13.CrossRef
7.
Chen J, Feng J, Wang X, Cai S, Dong J, Chen Y, et al. Risk scoring system and predictor for clinically relevant pancreatic fistula after pancreaticoduodenectomy. World J Gastroenterol, 2015. 21(19): p5926–33.
8.
Braga M, Capretti G, Pecorelli N, Balzano G, Doglioni C, Ariotti R, et al. A Prognostic Score to Predict Major Complications After Pancreaticoduodenectomy. Ann. Surg, 2011. 254: p702–8.CrossRef
9.
Welsch T, Müller SA, Ulrich A, Kischlat A. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Surgery, 2007: p1499–507.
10.
Facy O, Binquet C, Masson D, Fournel I, Rat P, Ortega-deballon P. Diagnostic Accuracy of Inflammatory Markers As Early Predictors of Infection After Elective Colorectal Surgery-Results From the IMACORS Study. Ann Surg, 2015. p1–6.
11.
Lagoutte N, Facy O, Ravoire A, Chalumeau C, Jonval L, Rat P, et al. C-reactive protein and procalcitonin for the early detection of anastomotic leakage after elective colorectal surgery : Pilot study in 100 patients. J. Visc. Surg, 2012. 149: p345–9
12.
Warschkow R, Tarantino I, Schmied BM, Steffen T. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after gastroesophageal cancer surgery. Langhenbecks Arch Surg, 2012. p727–36.
13.
Oberhofer D. Comparison of C-reactive protein and procalcitonin as predictors of postoperative infectious complications after elective colorectal surgery. CMJ, 2012. p612–9.
14.
Giaccaglia V, Salvi ÃPF, Antonelli ÃMS, Giacca M, Corcione F, Balducci G, et al. Procalcitonin Reveals Early Dehiscence in Colorectal Surgery The PREDICS Study. Ann Surg, 2015. 20(10): p1-6
15.
Bianchi RA, Silva NA, Natal ML. Utility of base deficit , lactic acid , microalbuminuria , and C-reactive protein in the early detection of complications in the immediate postoperative evolution. Clin Biochem, 2004. 37: p404–7.
16.
Siassi M, Riese J, Steffensen R, Meisner M, Thiel S, Hohenberger W, et al. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care, 2005. 9: p 483–9
17.
Bogar L, Molnar Z, Tarsoly P, Kenyeres P, Marton S. Serum procalcitonin level and leukocyte antisedimentation rate as early predictors of respiratory dysfunction after oesophageal tumour resection. Crit Care, 2006. 10(4): p2–6.CrossRef
18.
Meyer ZC, Schreinemakers JMJ, Waal RAL De. Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit : a review. Surg. Today, 2015. p1091–101.
19.
Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin , interleukin 6 and systemic inflammatory response syndrome ( SIRS ): early markers of postoperative sepsis after major surgery. B J Anaesth, 2005. 94: p767–73.
20.
Silvestre J, Rebanda J, Lourenço C, Póvoa P. Diagnostic accuracy of C-reactive protein and procalcitonin in the early detection of infection after elective colorectal surgery – a pilot study. BMC Infectious Disease, 2014. 1–8.
21.
Falcoz P et al. Usefulness of procalcitonin in the early detection of infection after thoracic surgery . Eur J Cardiothoracic Surg, 2005. 27: p1074–8.CrossRef
22.
Garcia-granero A, Frasson MDM, D BFP, Blanco F, Ph D, Puga R, et al. Procalcitonin and C-Reactive Protein as Early Predictors of Anastomotic Leak in Colorectal Surgery: A Prospective Observational Study. Dis Colon Rectum 2013. 56: p475–83.
23.
Callery MP, Pratt WB, Kent TS, Chaikof EL, Vollmer CM Jr. A prospective validated clinical score accurately predicts pancreatic fistula after pancreaticoduodenectomy. J Am Coll Surg, 2013. 216(1):1–14CrossRefPubMed
24.
Miller BC, Christein JD, Behrman SW, Drebin JA, Pratt WB, Callery MP, Vollmer CM Jr. A multi-institutional external validation of the fistula risk score for pancreaticoduodenectomy. J Gastrointest Surg. 2014. 18(1):172–79CrossRefPubMed
25.
Vallance AE, Young AL, Macutkiewicz C, Roberts KJ, Smith AM. Calculating the risk of a pancreatic fistula after a pancreaticoduodenectomy: a systematic review. Hpb J, 2015. 17: p1040–8.CrossRef
26.
Dindo D, Demartines N, Clavien P. Classification of Surgical Complications. Ann Surg 2004. 240: p205–13.CrossRef
27.
Kanda M, Fujii T, Takami H, Suenaga M, Inokawa Y, Yamada S. Novel diagnostics for aggravating pancreatic fistulas at the acute phase after pancreatectomy. World J Gatroenterol, 2014. 20: p8535–44.CrossRef
28.
Welsch T, Frommhold K, Hinz U, Weigand MA. Persisting elevation of C-reactive protein after pancreatic resections can indicate developing inflammatory complications. Surgery, 2008. 143: p20–8.CrossRef
29.
Warschkow R, Ukegjini K, Tarantino I, Steffen T, Lukas MS, Mu SA. Diagnostic study and meta-analysis of C-reactive protein as a predictor of postoperative inflammatory complications after pancreatic surgery. J Hepatobiliary Pancreatic Sci, 2012. 19: p492–500.CrossRef
30.
Bianchi RA, Haedo AS, Romero MC. Role of Plasma Procalcitonin determination in the post-operative follow-up of cephalic pancreaticoduodenectomy. Cir Esp, 2006. 79: p356–60.CrossRef
31.
Hoeboer SH, Groeneveld ABJ, Engels N, Genderen M Van. Rising C-Reactive Protein and Procalcitonin Levels Precede Early Complications After Esophagectomy. J Gastrointes Surg, 2015. 19: p613–24.
32.
Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med, 2002. 28: p1094–102.CrossRef
Metadata
Title
C-Reactive Protein and Procalcitonin as Predictors of Postoperative Inflammatory Complications After Pancreatic Surgery
Authors
A. Giardino
G. Spolverato
P. Regi
I. Frigerio
F. Scopelliti
R. Girelli
Z. Pawlik
P. Pederzoli
C. Bassi
G. Butturini
Publication date
01-08-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 8/2016
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-016-3171-6

Other articles of this Issue 8/2016

Journal of Gastrointestinal Surgery 8/2016 Go to the issue

GI Image

Giant Malignant Insulinoma

Original Article

Impact of Mucinous Histology on the Prognosis of Stage I–III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis

Original Article

Corticosteroids or Not for Postoperative Nausea: A Double-Blinded Randomized Study

Original Article

Application of FLEEOX Preoperative Chemotherapy via Intra-arterial and Intravenous Administration in Treatment of Unresectable Locally Advanced Gastric Cancer

Letter to the Editor

Response on: C-reactive Protein as a Predictor for Complications Following Esophagectomy

How I do it

Laparoscopic Total Gastrectomy with D2 Lymphadenectomy and Side-to-Side Stapled Esophagojejunostomy